Access cutting-edge breast cancer treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase II trial tests the accuracy of functional imaging (FFNP)-positron emission tomography (PET)/computed tomography (CT) to predict response to abemaciclib plus endocrine therapy. Abemaciclib is a drug used to treat certain types of hormone receptor positive (HR+), HER2 negative breast cancer. Abemaciclib blocks certain proteins, which may help keep tumor cells from growing. Endocrine therapy adds, blocks, or removes hormones that can cause cancer to grow. FFNP PET imaging is a form of x-
Sponsor: University of Washington
Check if you qualify for this breast cancer clinical trial in Seattle, WA
If you're searching for breast cancer treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.